Frontlight ResearchEarly access
Chronic kidney disease trials in Türkiye
13 of 24 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in TürkiyeA Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease Treated With Once Daily Basal Insulin Alone or in Combination With Metformin, SGLT2i, or Both
- Where
- Adana, Adapazarı/Turkiye, Afyonkarahisar, Ankara, Gaziantep, Izmir, Kartal/İstanbul, Kayseri, Kocaeli, Yüreğir/ADANA
- Age
- 18 years and over
- People
- 450 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07931547 · EU 2026-525471-13-00 - Phase 3Taking peopleA Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Where
- Adana, Adapazarı, Altındağ, Ankara, Antalya, Haliliye, Kahramanmaraş, Kayseri, Kocaeli, Şahinbey
- Age
- 18 years and over
- People
- 5,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00 - Phase 3Taking peopleA Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- Where
- Adana, Afyonkarahisar, Ankara, Antalya, Çanakkale, Çorum, Eskişehir, Istanbul, Kayseri, Kocaeli, Küçükçekmece, Malatya, Meram, Sakarya
- Age
- 50 years and over
- People
- 7,140 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00 - Phase 3Active, not recruitingA Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- Where
- Ankara, Antalya, Istanbul, Kayseri, Köseköy, Mersin
- Age
- 18 years to 100 years
- People
- 540 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00 - Phase 3WithdrawnA Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
- Where
- Adana, Ankara, Istanbul
- Age
- 1 year to 18 years
- People
- 100 worldwide
- Run by
- Bayer
See details and how to joinNCT05457283 · EU 2023-504885-50-00 - Phase 3Not yet taking people in TürkiyeA Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
- Where
- Adapazarı, Ankara, Antalya, Dinar, İzmit, Kahramanmaraş, Kayseri, Kazımkarabekir, Malatya, Samsun
- Age
- 18 years to 99 years
- People
- 2,800 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07624305 · EU 2026-526114-90-00 - Phase 2/3Taking peopleCombined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Where
- Ankara, Antalya, Atakum, Bakırköy, Bornova, Edirne, Gaziantep, İzmit, Kahramanmaraş, Yeşilyurt
- Age
- 18 years and over
- People
- 3,110 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00 - Phase 3Not yet taking people in TürkiyeA Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Where
- Adana, Ankara, Antalya, Bakırköy, Gaziantep, Kayseri, Yüreğir
- Age
- 18 years and over
- People
- 900 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662135 · EU 2025-523940-12-00 - Phase 3CompletedA Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
- Where
- Izmir, Kayseri, Kocaeli
- Age
- 18 years and over
- People
- 429 worldwide
- Run by
- Genexine, Inc.
See details and how to joinNCT06466785 - Phase 2Taking peopleA Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
- Where
- Adana, Ankara, Gaziantep, Istanbul, Izmir, Kayseri, Kocaeli
- Age
- 18 years and over
- People
- 465 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06717698 · EU 2024-510846-15-00 - Phase 3Taking peopleA Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
- Where
- Ankara, Elâzığ, Istanbul, Izmir, Kayseri
- Age
- 0 years to 18 years
- People
- 56 worldwide
- Run by
- Amgen
See details and how to joinNCT03633708 - No phaseNot yet taking people in TürkiyeEvaluation of the Effectiveness of a Mobile Application Developed for Hemodialysis Patients.
- Where
- Gümüşhane
- Age
- 18 years and over
- People
- 72
- Run by
- Saglik Bilimleri Universitesi
See details and how to joinNCT07211100 - No phaseEnrolling by invitationEffects of Intradialytic Exercise on Muscle Oxygenation and Dialysis Adequacy
- Where
- Istanbul
- Age
- 18 years to 65 years
- People
- 40
- Run by
- Istinye University
See details and how to joinNCT07151742